St Jude Medical, a global medical device company, has received European CE Mark approval for its new Athena programmer, a deep brain stimulation (DBS) therapy management system.
St Jude Medical claims that the platform offers clinicians an easy-to-use interface that enables them to set or adjust therapeutic parameters to optimise patient results. Additionally, the system has the most comprehensive data management capacity on the market, which will aid clinicians in the organization and storage of patient information.
The Athena programmer is a notebook-based PC that can be utilised through an interactive touch screen or keyboard according to the clinician’s preference and is used to program the Libra, LibraXP, and Brio DBS systems .
Chris Chavez, president of the St Jude Medical Neuromodulation Division said that because deep brain stimulation programming is often a complex and time-consuming process, we are pleased to provide physicians with this programmer.
“The Athena programmer addresses several unmet needs and presents physicians with a unique, new option in programming and the management of deep brain stimulation devices to advance this therapy,”
The Athena programmer is currently approved in European Union countries and is in the submission process for additional markets.